Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Non-Current Debt (2020)

Lexaria Bioscience's Non-Current Debt history spans 1 years, with the latest figure at $30852.0 for Q4 2020.

  • Quarterly results put Non-Current Debt at $30852.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Nov 2020 was $30852.0 (changed N/A YoY), and the annual figure for FY2020 was $30670.0, changed.
  • Non-Current Debt for Q4 2020 was $30852.0 at Lexaria Bioscience, up from $30670.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $30852.0 in Q4 2020 to a low of $28756.0 in Q2 2020.